Cryptosporidiosis: environmental, therapeutic, and preventive challenges

  • S. Collinet-AdlerEmail author
  • H. D. Ward


Cryptosporidium spp. are responsible for endemic and epidemic disease worldwide. Clinical manifestations may include acute, persistent, or chronic diarrhea, biliary, and pulmonary disease. Disease severity ranges from asymptomatic or mild to severe, intractable diarrhea with wasting depending on immune status, nutrition, and age. Transmission is fecal–oral with both human and animal reservoirs. Disease is often self limited in healthy individuals, but therapy remains a challenge in the immune-compromised. Prevention currently depends on appropriate hygiene and proper water management and treatment.


Mycobacterium Avium Complex Cryptosporidiosis Paromomycin Parasitophorous Vacuole Acalculous Cholecystitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



SCA receives research support through the NIH grant 2 T32 AI007329-16.

Conflict of interest



  1. 1.
    Tyzzer EE (1907) A sporozoan found in the peptic glands of the common mouse. Proc Soc Exp Biol Med 5:12–13Google Scholar
  2. 2.
    Meisel JL, Perera DR, Meligro C, Rubin CE (1976) Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology 70:1156–1160PubMedGoogle Scholar
  3. 3.
    Nime FA, Burek JD, Page DL, Holscher MA, Yardley JH (1976) Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology 70:592–598PubMedGoogle Scholar
  4. 4.
    Guerrant RL (1997) Cryptosporidiosis: an emerging, highly infectious threat. Emerg Infect Dis 3:51–57PubMedCrossRefGoogle Scholar
  5. 5.
    Ajjampur SS, Rajendran P, Ramani S, Banerjee I, Monica B, Sankaran P, Rosario V, Arumugam R, Sarkar R, Ward H, Kang G (2008) Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. J Med Microbiol 57:1364–1368PubMedCrossRefGoogle Scholar
  6. 6.
    Zu SX, Li JF, Barrett LJ, Fayer R, Shu SY, McAuliffe JF, Roche JK, Guerrant RL (1994) Seroepidemiologic study of Cryptosporidium infection in children from rural communities of Anhui, China and Fortaleza, Brazil. Am J Trop Med Hyg 51:1–10PubMedGoogle Scholar
  7. 7.
    Newman RD, Zu SX, Wuhib T, Lima AA, Guerrant RL, Sears CL (1994) Household epidemiology of Cryptosporidium parvum infection in an urban community in northeast Brazil. Ann Intern Med 120:500–505PubMedGoogle Scholar
  8. 8.
    Kozisek F, Craun GF, Cerovska L, Pumann P, Frost F, Muller T (2008) Serological responses to Cryptosporidium-specific antigens in Czech populations with different water sources. Epidemiol Infect 136:279–286PubMedCrossRefGoogle Scholar
  9. 9.
    Egorov A, Frost F, Muller T, Naumova E, Tereschenko A, Ford T (2004) Serological evidence of Cryptosporidium infections in a Russian city and evaluation of risk factors for infections. Ann Epidemiol 14:129–136PubMedCrossRefGoogle Scholar
  10. 10.
    Steinberg EB, Mendoza CE, Glass R, Arana B, Lopez MB, Mejia M, Gold BD, Priest JW, Bibb W, Monroe SS, Bern C, Bell BP, Hoekstra RM, Klein R, Mintz ED, Luby S (2004) Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6-36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg 70:83–88PubMedGoogle Scholar
  11. 11.
    Frost FJ, Muller T, Craun GF, Lockwood WB, Calderon RL (2002) Serological evidence of endemic waterborne cryptosporidium infections. Ann Epidemiol 12:222–227PubMedCrossRefGoogle Scholar
  12. 12.
    Frost FJ, Fea E, Gilli G, Biorci F, Muller TM, Craun GF, Calderon RL (2000) Serological evidence of Cryptosporidium infections in southern Europe. Eur J Epidemiol 16:385–390PubMedCrossRefGoogle Scholar
  13. 13.
    Isaac-Renton J, Blatherwick J, Bowie WR, Fyfe M, Khan M, Li A, King A, McLean M, Medd L, Moorehead W, Ong CS, Robertson W (1999) Epidemic and endemic seroprevalence of antibodies to Cryptosporidium and Giardia in residents of three communities with different drinking water supplies. Am J Trop Med Hyg 60:578–583PubMedGoogle Scholar
  14. 14.
    Centers for Disease Control and Prevention (CDC) (2008) Communitywide cryptosporidiosis outbreak—Utah, 2007. MMWR Morb Mortal Wkly Rep 57:989–993Google Scholar
  15. 15.
    Jokipii L, Jokipii AM (1986) Timing of symptoms and oocyst excretion in human cryptosporidiosis. N Engl J Med 315:1643–1647PubMedGoogle Scholar
  16. 16.
    Van Gool T, Weijts R, Lommerse E, Mank TG (2003) Triple Faeces Test: an effective tool for detection of intestinal parasites in routine clinical practice. Eur J Clin Microbiol Infect Dis 22:284–290PubMedGoogle Scholar
  17. 17.
    Centers for Disease Control and Prevention (CDC) (1999) False-positive laboratory tests for Cryptosporidium involving an enzyme-linked immunosorbent assay—United States, November 1997–March 1998. MMWR Morb Mortal Wkly Rep 48:4–8Google Scholar
  18. 18.
    Robinson G, Watkins J, Chalmers RM (2008) Evaluation of a modified semi-automated immunomagnetic separation technique for the detection of Cryptosporidium oocysts in human faeces. J Microbiol Meth 75:139–141CrossRefGoogle Scholar
  19. 19.
    Rochelle PA, Ferguson DM, Johnson AM, De Leon R (2001) Quantitation of Cryptosporidium parvum infection in cell culture using a colorimetric in situ hybridization assay. J Eukaryot Microbiol 48:565–574PubMedCrossRefGoogle Scholar
  20. 20.
    Xiao L (2010) Molecular epidemiology of cryptosporidiosis: an update. Exp Parasitol 124:80–89PubMedCrossRefGoogle Scholar
  21. 21.
    In: Method 1623: Cryptosporidium andGiardia in Water by Filtration/IMS/FA. Accessed 17 December 2009
  22. 22.
    Jenkins MB, Anguish LJ, Bowman DD, Walker MJ, Ghiorse WC (1997) Assessment of a dye permeability assay for determination of inactivation rates of Cryptosporidium parvum oocysts. Appl Environ Microbiol 63:3844–3850PubMedGoogle Scholar
  23. 23.
    Bukhari Z, Marshall MM, Korich DG, Fricker CR, Smith HV, Rosen J, Clancy JL (2000) Comparison of Cryptosporidium parvum viability and infectivity assays following ozone treatment of oocysts. Appl Environ Microbiol 66:2972–2980PubMedCrossRefGoogle Scholar
  24. 24.
    Lemos V, Graczyk TK, Alves M, Lobo ML, Sousa MC, Antunes F, Matos O (2005) Identification and determination of the viability of Giardia lamblia cysts and Cryptosporidium parvum and Cryptosporidium hominis oocysts in human fecal and water supply samples by fluorescent in situ hybridization (FISH) and monoclonal antibodies. Parasitol Res 98:48–53PubMedCrossRefGoogle Scholar
  25. 25.
    Alagappan A, Tujula NA, Power M, Ferguson CM, Bergquist PL, Ferrari BC (2008) Development of fluorescent in situ hybridization for Cryptosporidium detection reveals zoonotic and anthroponotic transmission of sporadic cryptosporidiosis in Sydney. J Microbiol Meth 75:535–539CrossRefGoogle Scholar
  26. 26.
    Alagappan A, Bergquist PL, Ferrari BC (2009) Development of a two-color fluorescence in situ hybridization technique for species-level identification of human-infectious Cryptosporidium spp. Appl Environ Microbiol 75:5996–5998PubMedCrossRefGoogle Scholar
  27. 27.
    Jenkins M, Trout JM, Higgins J, Dorsch M, Veal D, Fayer R (2003) Comparison of tests for viable and infectious Cryptosporidium parvum oocysts. Parasitol Res 89:1–5PubMedCrossRefGoogle Scholar
  28. 28.
    Rochelle PA, Marshall MM, Mead JR, Johnson AM, Korich DG, Rosen JS, De Leon R (2002) Comparison of in vitro cell culture and a mouse assay for measuring infectivity of Cryptosporidium parvum. Appl Environ Microbiol 68:3809–3817PubMedCrossRefGoogle Scholar
  29. 29.
    Tzipori S, Ward H (2002) Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect 4:1047–1058PubMedCrossRefGoogle Scholar
  30. 30.
    Chen XM, Keithly JS, Paya CV, LaRusso NF (2002) Cryptosporidiosis. N Engl J Med 346:1723–1731PubMedCrossRefGoogle Scholar
  31. 31.
    Caccio SM, Thompson RC, McLauchlin J, Smith HV (2005) Unravelling Cryptosporidium and Giardia epidemiology. Trends Parasitol 21:430–437PubMedCrossRefGoogle Scholar
  32. 32.
    Leav BA, Mackay M, Ward HD (2003) Cryptosporidium species: new insights and old challenges. Clin Infect Dis 36:903–908PubMedCrossRefGoogle Scholar
  33. 33.
    Martinez-Giron R, Esteban JG, Ribas A, Doganci L (2008) Protozoa in respiratory pathology: a review. Eur Respir J 32:1354–1370PubMedCrossRefGoogle Scholar
  34. 34.
    Chalmers RM, Davies AP (2010) Minireview: clinical cryptosporidiosis. Exp Parasitol 124:138–146PubMedCrossRefGoogle Scholar
  35. 35.
    Graczyk TK, Fayer R, Knight R, Mhangami-Ruwende B, Trout JM, Da Silva AJ, Pieniazek NJ (2000) Mechanical transport and transmission of Cryptosporidium parvum oocysts by wild filth flies. Am J Trop Med Hyg 63:178–183PubMedGoogle Scholar
  36. 36.
    Miller WA, Lewis DJ, Pereira MD, Lennox M, Conrad PA, Tate KW, Atwill ER (2008) Farm factors associated with reducing Cryptosporidium loading in storm runoff from dairies. J Environ Qual 37:1875–1882PubMedCrossRefGoogle Scholar
  37. 37.
    Mahdi NK, Ali NH (2002) Cryptosporidiosis among animal handlers and their livestock in Basrah, Iraq. East Afr Med J 79:550–553PubMedGoogle Scholar
  38. 38.
    Robertson LJ (2009) Giardia and Cryptosporidium infections in sheep and goats: a review of the potential for transmission to humans via environmental contamination. Epidemiol Infect 137:913–921PubMedCrossRefGoogle Scholar
  39. 39.
    Smerdon WJ, Nichols T, Chalmers RM, Heine H, Reacher MH (2003) Foot and mouth disease in livestock and reduced cryptosporidiosis in humans, England and Wales. Emerg Infect Dis 9:22–28PubMedGoogle Scholar
  40. 40.
    Huetink RE, van der Giessen JW, Noordhuizen JP, Ploeger HW (2001) Epidemiology of Cryptosporidium spp. and Giardia duodenalis on a dairy farm. Vet Parasitol 102:53–67PubMedCrossRefGoogle Scholar
  41. 41.
    King BJ, Keegan AR, Monis PT, Saint CP (2005) Environmental temperature controls Cryptosporidium oocyst metabolic rate and associated retention of infectivity. Appl Environ Microbiol 71:3848–3857PubMedCrossRefGoogle Scholar
  42. 42.
    Deng MQ, Cliver DO (1999) Cryptosporidium parvum studies with dairy products. Int J Food Microbiol 46:113–121PubMedCrossRefGoogle Scholar
  43. 43.
    McGuigan KG, Mendez-Hermida F, Castro-Hermida JA, Ares-Mazas E, Kehoe SC, Boyle M, Sichel C, Fernandez-Ibanez P, Meyer BP, Ramalingham S, Meyer EA (2006) Batch solar disinfection inactivates oocysts of Cryptosporidium parvum and cysts of Giardia muris in drinking water. J Appl Microbiol 101:453–463PubMedCrossRefGoogle Scholar
  44. 44.
    King BJ, Hoefel D, Daminato DP, Fanok S, Monis PT (2008) Solar UV reduces Cryptosporidium parvum oocyst infectivity in environmental waters. J Appl Microbiol 104:1311–1323PubMedCrossRefGoogle Scholar
  45. 45.
    Connelly SJ, Wolyniak EA, Williamson CE, Jellison KL (2007) Artificial UV-B and solar radiation reduce in vitro infectivity of the human pathogen Cryptosporidium parvum. Environ Sci Technol 41:7101–7106PubMedCrossRefGoogle Scholar
  46. 46.
    Linden KG, Shin G, Sobsey MD (2001) Comparative effectiveness of UV wavelengths for the inactivation of Cryptosporidium parvum oocysts in water. Water Sci Technol 43:171–174PubMedGoogle Scholar
  47. 47.
    Lorenzo-Lorenzo MJ, Ares-Mazas ME, Villacorta-Martinez de Maturana I, Duran-Oreiro D (1993) Effect of ultraviolet disinfection of drinking water on the viability of Cryptosporidium parvum oocysts. J Parasitol 79:67–70PubMedCrossRefGoogle Scholar
  48. 48.
    Rochelle PA, Fallar D, Marshall MM, Montelone BA, Upton SJ, Woods K (2004) Irreversible UV inactivation of Cryptosporidium spp. despite the presence of UV repair genes. J Eukaryot Microbiol 51:553–562PubMedCrossRefGoogle Scholar
  49. 49.
    Johnson AM, Linden K, Ciociola KM, De Leon R, Widmer G, Rochelle PA (2005) UV inactivation of Cryptosporidium hominis as measured in cell culture. Appl Environ Microbiol 71:2800–2802PubMedCrossRefGoogle Scholar
  50. 50.
    Atwill ER, Tate KW, Pereira MD, Bartolome J, Nader G (2006) Efficacy of natural grassland buffers for removal of Cryptosporidium parvum in rangeland runoff. J Food Prot 69:177–184PubMedGoogle Scholar
  51. 51.
    Bodley-Tickell AT, Kitchen SE, Sturdee AP (2002) Occurrence of Cryptosporidium in agricultural surface waters during an annual farming cycle in lowland UK. Water Res 36:1880–1886PubMedCrossRefGoogle Scholar
  52. 52.
    Naumova EN, Jagai JS, Matyas B, DeMaria A Jr, MacNeill IB, Griffiths JK (2007) Seasonality in six enterically transmitted diseases and ambient temperature. Epidemiol Infect 135:281–292PubMedCrossRefGoogle Scholar
  53. 53.
    Jagai JS, Castronovo DA, Monchak J, Naumova EN (2009) Seasonality of cryptosporidiosis: a meta-analysis approach. Environ Res 109:465–478PubMedCrossRefGoogle Scholar
  54. 54.
    Muchiri JM, Ascolillo L, Mugambi M, Mutwiri T, Ward HD, Naumova EN, Egorov AI, Cohen S, Else JG, Griffiths JK (2009) Seasonality of Cryptosporidium oocyst detection in surface waters of Meru, Kenya as determined by two isolation methods followed by PCR. J Water Health 7:67–75PubMedCrossRefGoogle Scholar
  55. 55.
    Okhuysen PC, Rich SM, Chappell CL, Grimes KA, Widmer G, Feng X, Tzipori S (2002) Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-gamma knockout mice. J Infect Dis 185:1320–1325PubMedCrossRefGoogle Scholar
  56. 56.
    Messner MJ, Chappell CL, Okhuysen PC (2001) Risk assessment for Cryptosporidium: a hierarchical Bayesian analysis of human dose response data. Water Res 35:3934–3940PubMedCrossRefGoogle Scholar
  57. 57.
    Chappell CL, Okhuysen PC, Langer-Curry R, Widmer G, Akiyoshi DE, Tanriverdi S, Tzipori S (2006) Cryptosporidium hominis: experimental challenge of healthy adults. Am J Trop Med Hyg 75:851–857PubMedGoogle Scholar
  58. 58.
    DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W (1995) The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 332:855–859PubMedCrossRefGoogle Scholar
  59. 59.
    Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL (1999) Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J Infect Dis 180:1275–1281PubMedCrossRefGoogle Scholar
  60. 60.
    Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL (1998) Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect Immun 66:441–443PubMedGoogle Scholar
  61. 61.
    Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL (1999) Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am J Trop Med Hyg 60:157–164PubMedGoogle Scholar
  62. 62.
    MacKenzie WR, Hoxie NJ, Proctor ME, Gradus MS, Blair KA, Peterson DE, Kazmierczak JJ, Addiss DG, Fox KR, Rose JB (1994) A massive outbreak in Milwaukee of cryptosporidium infection transmitted through the public water supply. N Engl J Med 331:161–167CrossRefGoogle Scholar
  63. 63.
    Pawlowski SW, Warren CA, Guerrant R (2009) Diagnosis and treatment of acute or persistent diarrhea. Gastroenterology 136:1874–1886PubMedCrossRefGoogle Scholar
  64. 64.
    Dillingham RA, Lima AA, Guerrant RL (2002) Cryptosporidiosis: epidemiology and impact. Microbes Infect 4:1059–1066PubMedCrossRefGoogle Scholar
  65. 65.
    Khan WA, Rogers KA, Karim MM, Ahmed S, Hibberd PL, Calderwood SB, Ryan ET, Ward HD (2004) Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. Am J Trop Med Hyg 71:412–419PubMedGoogle Scholar
  66. 66.
    Egger M, Mausezahl D, Odermatt P, Marti HP, Tanner M (1990) Symptoms and transmission of intestinal cryptosporidiosis. Arch Dis Child 65:445–447PubMedCrossRefGoogle Scholar
  67. 67.
    Hunter PR, Hughes S, Woodhouse S, Raj N, Syed Q, Chalmers RM, Verlander NQ, Goodacre J (2004) Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin Infect Dis 39:504–510PubMedCrossRefGoogle Scholar
  68. 68.
    Vakil NB, Schwartz SM, Buggy BP, Brummitt CF, Kherellah M, Letzer DM, Gilson IH, Jones PG (1996) Biliary cryptosporidiosis in HIV-infected people after the waterborne outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 334:19–23PubMedCrossRefGoogle Scholar
  69. 69.
    Lopez-Velez R, Tarazona R, Garcia Camacho A, Gomez-Mampaso E, Guerrero A, Moreira V, Villanueva R (1995) Intestinal and extraintestinal cryptosporidiosis in AIDS patients. Eur J Clin Microbiol Infect Dis 14:677–681PubMedCrossRefGoogle Scholar
  70. 70.
    Ives NJ, Gazzard BG, Easterbrook PJ (2001) The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect 42:134–139PubMedCrossRefGoogle Scholar
  71. 71.
    Zardi EM, Picardi A, Afeltra A (2005) Treatment of cryptosporidiosis in immunocompromised hosts. Chemotherapy 51:193–196PubMedCrossRefGoogle Scholar
  72. 72.
    Guerrant DI, Moore SR, Lima AA, Patrick PD, Schorling JB, Guerrant RL (1999) Association of early childhood diarrhea and cryptosporidiosis with impaired physical fitness and cognitive function four–seven years later in a poor urban community in northeast Brazil. Am J Trop Med Hyg 61:707–713PubMedGoogle Scholar
  73. 73.
    Checkley W, Buckley G, Gilman RH, Assis AM, Guerrant RL, Morris SS, Molbak K, Valentiner-Branth P, Lanata CF, Black RE, Malnutrition C, Network I (2008) Multi-country analysis of the effects of diarrhoea on childhood stunting. Int J Epidemiol 37:816–830PubMedGoogle Scholar
  74. 74.
    Molbak K, Andersen M, Aaby P, Hojlyng N, Jakobsen M, Sodemann M, da Silva AP (1997) Cryptosporidium infection in infancy as a cause of malnutrition: a community study from Guinea-Bissau, west Africa. Am J Clin Nutr 65:149–152PubMedGoogle Scholar
  75. 75.
    Kirkpatrick BD, Noel F, Rouzier PD, Powell JL, Pape JW, Bois G, Alston WK, Larsson CJ, Tenney K, Ventrone C, Powden C, Sreenivasan M, Sears CL (2006) Childhood cryptosporidiosis is associated with a persistent systemic inflammatory response. Clin Infect Dis 43:604–608PubMedCrossRefGoogle Scholar
  76. 76.
    Molbak K, Hojlyng N, Gottschau A, Sa JC, Ingholt L, da Silva AP, Aaby P (1993) Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. BMJ 307:417–420PubMedCrossRefGoogle Scholar
  77. 77.
    Yang W, Chen P, Villegas EN, Landy RB, Kanetsky C, Cama V, Dearen T, Schultz CL, Orndorff KG, Prelewicz GJ, Brown MH, Young KR, Xiao L (2008) Cryptosporidium source tracking in the Potomac River watershed. Appl Environ Microbiol 74:6495–6504PubMedCrossRefGoogle Scholar
  78. 78.
    Morgan-Ryan UM, Fall A, Ward LA, Hijjawi N, Sulaiman I, Fayer R, Thompson RC, Olson M, Lal A, Xiao L (2002) Cryptosporidium hominis n. sp. (Apicomplexa: Cryptosporidiidae) from Homo sapiens. J Eukaryot Microbiol 49:433–440PubMedCrossRefGoogle Scholar
  79. 79.
    Baishanbo A, Gargala G, Delaunay A, Francois A, Ballet JJ, Favennec L (2005) Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils. Infect Immun 73:5252–5255PubMedCrossRefGoogle Scholar
  80. 80.
    Bushen OY, Kohli A, Pinkerton RC, Dupnik K, Newman RD, Sears CL, Fayer R, Lima AA, Guerrant RL (2007) Heavy cryptosporidial infections in children in northeast Brazil: comparison of Cryptosporidium hominis and Cryptosporidium parvum. Trans R Soc Trop Med Hyg 101:378–384PubMedCrossRefGoogle Scholar
  81. 81.
    Ajjampur SS, Gladstone BP, Selvapandian D, Muliyil JP, Ward H, Kang G (2007) Molecular and spatial epidemiology of cryptosporidiosis in children in a semiurban community in South India. J Clin Microbiol 45:915–920PubMedCrossRefGoogle Scholar
  82. 82.
    Cama VA, Bern C, Roberts J, Cabrera L, Sterling CR, Ortega Y, Gilman RH, Xiao L (2008) Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg Infect Dis 14:1567–1574PubMedCrossRefGoogle Scholar
  83. 83.
    Rao Ajjampur SS, Asirvatham JR, Muthusamy D, Gladstone BP, Abraham OC, Mathai D, Ward H, Wanke C, Kang G (2007) Clinical features & risk factors associated with cryptosporidiosis in HIV infected adults in India. Indian J Med Res 126:553–557PubMedGoogle Scholar
  84. 84.
    Cama VA, Ross JM, Crawford S, Kawai V, Chavez-Valdez R, Vargas D, Vivar A, Ticona E, Navincopa M, Williamson J, Ortega Y, Gilman RH, Bern C, Xiao L (2007) Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J Infect Dis 196:684–691PubMedCrossRefGoogle Scholar
  85. 85.
    Schmidt W, Wahnschaffe U, Schafer M, Zippel T, Arvand M, Meyerhans A, Riecken EO, Ullrich R (2001) Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology 120:984–987PubMedCrossRefGoogle Scholar
  86. 86.
    Pozio E, Rezza G, Boschini A, Pezzotti P, Tamburrini A, Rossi P, Di Fine M, Smacchia C, Schiesari A, Gattei E, Zucconi R, Ballarini P (1997) Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug users. J Infect Dis 176:969–975PubMedCrossRefGoogle Scholar
  87. 87.
    Riggs MW (2002) Recent advances in cryptosporidiosis: the immune response. Microbes Infect 4:1067–1080PubMedCrossRefGoogle Scholar
  88. 88.
    Theodos CM (1998) Innate and cell-mediated immune responses to Cryptosporidium parvum. Adv Parasitol 40:87–119PubMedCrossRefGoogle Scholar
  89. 89.
    Theodos CM, Sullivan KL, Griffiths JK, Tzipori S (1997) Profiles of healing and nonhealing Cryptosporidium parvum infection in C57BL/6 mice with functional B and T lymphocytes: the extent of gamma interferon modulation determines the outcome of infection. Infect Immun 65:4761–4769PubMedGoogle Scholar
  90. 90.
    Robinson P, Okhuysen PC, Chappell CL, Lewis DE, Shahab I, Lahoti S, White AC Jr (2001) Expression of IL-15 and IL-4 in IFN-gamma-independent control of experimental human Cryptosporidium parvum infection. Cytokine 15:39–46PubMedCrossRefGoogle Scholar
  91. 91.
    Lean IS, McDonald SA, Bajaj-Elliott M, Pollok RC, Farthing MJ, McDonald V (2003) Interleukin-4 and transforming growth factor beta have opposing regulatory effects on gamma interferon-mediated inhibition of Cryptosporidium parvum reproduction. Infect Immun 71:4580–4585PubMedCrossRefGoogle Scholar
  92. 92.
    Hunter PR, Nichols G (2002) Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin Microbiol Rev 15:145–154PubMedCrossRefGoogle Scholar
  93. 93.
    Carmolli M, Duggal P, Haque R, Lindow J, Mondal D, Petri WA Jr, Mourningstar P, Larsson CJ, Sreenivasan M, Khan S, Kirkpatrick BD (2009) Deficient serum mannose-binding lectin levels and MBL2 polymorphisms increase the risk of single and recurrent Cryptosporidium infections in young children. J Infect Dis 200:1540–1547PubMedCrossRefGoogle Scholar
  94. 94.
    Moss DM, Chappell CL, Okhuysen PC, DuPont HL, Arrowood MJ, Hightower AW, Lammie PJ (1998) The antibody response to 27-, 17-, and 15-kDa Cryptosporidium antigens following experimental infection in humans. J Infect Dis 178:827–833PubMedCrossRefGoogle Scholar
  95. 95.
    Bhattacharya MK, Teka T, Faruque AS, Fuchs GJ (1997) Cryptosporidium infection in children in urban Bangladesh. J Trop Pediatr 43:282–286PubMedCrossRefGoogle Scholar
  96. 96.
    Molbak K, Aaby P, Hojlyng N, da Silva AP (1994) Risk factors for Cryptosporidium diarrhea in early childhood: a case-control study from Guinea-Bissau, West Africa. Am J Epidemiol 139:734–740PubMedGoogle Scholar
  97. 97.
    Nchito M, Kelly P, Sianongo S, Luo NP, Feldman R, Farthing M, Baboo KS (1998) Cryptosporidiosis in urban Zambian children: an analysis of risk factors. Am J Trop Med Hyg 59:435–437PubMedGoogle Scholar
  98. 98.
    Sterling CR, Gilman RH, Sinclair NA, Cama V, Castillo R, Diaz F (1991) The role of breast milk in protecting urban Peruvian children against cryptosporidiosis. J Protozool 38:23S–25SPubMedGoogle Scholar
  99. 99.
    Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol 124:45–53PubMedCrossRefGoogle Scholar
  100. 100.
    Hommer V, Eichholz J, Petry F (2003) Effect of antiretroviral protease inhibitors alone, and in combination with paromomycin, on the excystation, invasion and in vitro development of Cryptosporidium parvum. J Antimicrob Chemother 52:359–364PubMedCrossRefGoogle Scholar
  101. 101.
    Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P (2002) Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet 360:1375–1380PubMedCrossRefGoogle Scholar
  102. 102.
    Amadi B, Mwiya M, Sianongo S, Payne L, Watuka A, Katubulushi M, Kelly P (2009) High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 9:195PubMedCrossRefGoogle Scholar
  103. 103.
    Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF (2000) Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group. Clin Infect Dis 31:1084–1092PubMedCrossRefGoogle Scholar
  104. 104.
    McMeeking A, Borkowsky W, Klesius PH, Bonk S, Holzman RS, Lawrence HS (1990) A controlled trial of bovine dialyzable leukocyte extract for cryptosporidiosis in patients with AIDS. J Infect Dis 161:108–112PubMedGoogle Scholar
  105. 105.
    Nord J, Ma P, DiJohn D, Tzipori S, Tacket CO (1990) Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients. AIDS 4:581–584PubMedCrossRefGoogle Scholar
  106. 106.
    Abubakar I, Aliyu SH, Arumugam C, Hunter PR, Usman NK (2007) Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev (1):CD004932Google Scholar
  107. 107.
    Fichtenbaum CJ, Zackin R, Feinberg J, Benson C, Griffiths JK, AIDS Clinical Trials Group New Works Concept Sheet Team 064 (2000) Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection. AIDS 14:2889–2893PubMedCrossRefGoogle Scholar
  108. 108.
    Holmberg SD, Moorman AC, Von Bargen JC, Palella FJ, Loveless MO, Ward DJ, Navin TR (1998) Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. JAMA 279:384–386PubMedCrossRefGoogle Scholar
  109. 109.
    Jenkins MC, O’Brien C, Trout J, Guidry A, Fayer R (1999) Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice. Vaccine 17:2453–2460PubMedCrossRefGoogle Scholar
  110. 110.
    Doyle PS, Crabb J, Petersen C (1993) Anti-Cryptosporidium parvum antibodies inhibit infectivity in vitro and in vivo. Infect Immun 61:4079–4084PubMedGoogle Scholar
  111. 111.
    Okhuysen PC, Chappell CL, Crabb J, Valdez LM, Douglass ET, DuPont HL (1998) Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum. Clin Infect Dis 26:1324–1329PubMedCrossRefGoogle Scholar
  112. 112.
    Betancourt WQ, Rose JB (2004) Drinking water treatment processes for removal of Cryptosporidium and Giardia. Vet Parasitol 126:219–234PubMedCrossRefGoogle Scholar
  113. 113.
    Mendez-Hermida F, Ares-Mazas E, McGuigan KG, Boyle M, Sichel C, Fernandez-Ibanez P (2007) Disinfection of drinking water contaminated with Cryptosporidium parvum oocysts under natural sunlight and using the photocatalyst TiO2. J Photochem Photobiol B 88:105–111PubMedCrossRefGoogle Scholar
  114. 114.
    King BJ, Monis PT (2007) Critical processes affecting Cryptosporidium oocyst survival in the environment. Parasitology 134:309–323PubMedCrossRefGoogle Scholar
  115. 115.
    Graczyk TK, Lucy FE, Tamang L, Mashinski Y, Broaders MA, Connolly M, Cheng HW (2009) Propagation of human enteropathogens in constructed horizontal wetlands used for tertiary wastewater treatment. Appl Environ Microbiol 75:4531–4538PubMedCrossRefGoogle Scholar
  116. 116.
    Fewtrell L, Kaufmann RB, Kay D, Enanoria W, Haller L, Colford JM Jr (2005) Water, sanitation, and hygiene interventions to reduce diarrhoea in less developed countries: a systematic review and meta-analysis. Lancet Infect Dis 5:42–52PubMedCrossRefGoogle Scholar
  117. 117.
    Clasen T, Schmidt WP, Rabie T, Roberts I, Cairncross S (2007) Interventions to improve water quality for preventing diarrhoea: systematic review and meta-analysis. BMJ 334:782PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Division of Geographic Medicine and Infectious DiseasesTufts Medical CenterBostonUSA
  2. 2.Tufts UniversityBostonUSA
  3. 3.Tufts Medical CenterBostonUSA

Personalised recommendations